Home › Funds › MARSICO CAPITAL MANAGEMENT LLC › RVMD
MARSICO CAPITAL MANAGEMENT LLC position in RVMD
REVOLUTION MEDICINES INC · Health Care
MARSICO CAPITAL MANAGEMENT LLC reported holding 219,460 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$45.0M, representing 1.12% of its reported portfolio and ranking #23 among its reported holdings. MARSICO CAPITAL MANAGEMENT LLC has disclosed RVMD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How MARSICO CAPITAL MANAGEMENT LLC's RVMD position evolved
MARSICO CAPITAL MANAGEMENT LLC first disclosed a stake in RVMD in Q4 2025 at 219,460 shares (US$17.5M). The position peaked in Q3 2026 at 219,460 shares, worth US$45.0M. Across 4 filings, MARSICO CAPITAL MANAGEMENT LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 219,460 shares valued at US$45.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 219.46K | $17.48M | New |
| Q1 2026 | 219.46K | $21.34M | Hold |
| Q2 2026 | 219.46K | $41.10M | Hold |
| Q3 2026 | 219.46K | $45.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RVMD and 13F data
RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 58 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RVMD
- Farallon Capital Management 13.55M sh · $2.54B · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.55M sh · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 11.44M sh · $2.14B · Q2 2026
- Darwin Global Management, Ltd. 10.63M sh · $2.05B · Q2 2026
- Nextech Invest Ltd. 7.60M sh · $1.42B · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $1.19B · Q2 2026
- Janus Henderson Group 9.77M sh · $949.54M · Q1 2026
- BVF INC/IL 2.97M sh · $555.32M · Q2 2026
- Alphabet Inc. 2.67M sh · $548.85M · Q3 2026
- Casdin Capital 2.58M sh · $482.68M · Q2 2026
- Assenagon Asset Management S.A. 2.18M sh · $447.71M · Q3 2026
- Avoro Capital Advisors LLC 2.30M sh · $430.18M · Q2 2026
More on MARSICO CAPITAL MANAGEMENT LLC
FAQ
How long has MARSICO CAPITAL MANAGEMENT LLC held RVMD?
MARSICO CAPITAL MANAGEMENT LLC has disclosed RVMD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is MARSICO CAPITAL MANAGEMENT LLC's current position in RVMD?
As of Q3 2026, MARSICO CAPITAL MANAGEMENT LLC holds 219.46K shares of RVMD (REVOLUTION MEDICINES INC), valued at $45.05M, representing 1.12% of its reported portfolio and ranking #23.
Has MARSICO CAPITAL MANAGEMENT LLC been buying or selling RVMD?
In the latest 13F filing (Q3 2026), MARSICO CAPITAL MANAGEMENT LLC held unchanged its position in RVMD. The position peaked in Q3 2026 at 219.46K shares.
Which other funds hold RVMD?
Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.